Serveur d'exploration sur la maladie de Parkinson - Analysis (USA)

Index « ISSN » - entrée « 0006-8993 »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
0006-8950 < 0006-8993 < 0007-0769  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 22.
[0-20] [0 - 20][0 - 22][20-21][20-40]
Ident.Authors (with country if any)Title
000964 (2000) A. Björklund [Suède] ; D. Kirik [Suède] ; C. Rosenblad [Danemark] ; B. Georgievska [Suède] ; C. Lundberg [Suède] ; R. J. Mandel [États-Unis]Towards a neuroprotective gene therapy for Parkinson’s disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model
000972 (2000) Ken Nakamura [États-Unis] ; Lisa Won [États-Unis] ; Alfred Heller [États-Unis] ; Un Jung Kang [États-Unis]Preferential resistance of dopaminergic neurons to glutathione depletion in a reconstituted nigrostriatal system
000977 (2000) Wenbo Zhou [États-Unis] ; Marc S. Hurlbert [États-Unis] ; Jerome Schaack [États-Unis] ; Kedar N. Prasad [États-Unis] ; Curt R. Freed [États-Unis]Overexpression of human α-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells
000B12 (1997) Anumantha G. Kanthasamy [États-Unis] ; Arthi Kanthasamy [États-Unis] ; Rae R. Matsumoto [États-Unis] ; Toan Q. Vu [États-Unis] ; Daniel D. Truong [États-Unis]Neuroprotective effects of the strychnine-insensitive glycine site NMDA antagonist ( R )-HA-966 in an experimental model of Parkinson's disease
000B21 (1997) Kimberly A. Disshon [États-Unis] ; Dean E. Dluzen [États-Unis]Estrogen as a neuromodulator of MPTP-induced neurotoxicity: effects upon striatal dopamine release
000B25 (1997) Margaret M. Tompkins [États-Unis] ; William D. Hill [États-Unis]Contribution of somal Lewy bodies to neuronal death
000B56 (1996) Michael S. Cousins [États-Unis] ; John D. Salamone [États-Unis]Skilled motor deficits in rats induced by ventrolateral striatal dopamine depletions: behavioral and pharmacological characterization
000B67 (1996) R. Castellani [États-Unis] ; M. A. Smith [États-Unis] ; G. L. Richey [États-Unis] ; G. Perry [États-Unis]Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease
000B70 (1996) Dean E. Dluzen [États-Unis]Effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system of C57/B1 mice
000B81 (1996) J. S Schneider [États-Unis] ; David S. Rothblat [États-Unis]Alterations in intralaminar and motor thalamic physiology following nigrostriatal dopamine depletion
000C85 (1993) Jeffrey N. Joyce [États-Unis]Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. III. Results in Parkinson's disease cases
000D14 (1992) Larry Baum [États-Unis] ; Eliezer Masliah [États-Unis] ; Devin S. Iimoto [États-Unis] ; Lawrence A. Hansen [États-Unis] ; William C. Halliday ; Tsunao Saitoh [États-Unis]Casein kinase II is associated with neurofibrillary tangles but is not an intrinsic component of paired helical filaments
000D15 (1992) George Perry [États-Unis] ; Peggy Richey [États-Unis] ; Sandra L. Siedlak [États-Unis] ; Pamela Galloway [États-Unis] ; Mitsuru Kawai [États-Unis] ; Patrick Cras [États-Unis]Basic fibroblast growth factor binds to filamentous inclusions of neurodegenerative diseases
000D26 (1991) Pamela G. Galloway [États-Unis] ; George Perry [États-Unis]Tropomyosin distinguishes Lewy bodies of Parkinson disease from other neurofibrillary pathology
000D28 (1991) J. S. Schneider [États-Unis]Responses of striatal neurons to peripheral sensory stimulation in symptomatic MPTP-exposed cats
000D31 (1991) Fabio Baronti [États-Unis] ; Katherine E. Conant [États-Unis] ; Marianne Giuffra [États-Unis] ; Thomas L. Davis [États-Unis] ; Giorgio Brughitta [États-Unis] ; Michael J. Iadarola [États-Unis] ; Wade H. Berrettini [États-Unis] ; Thomas N. Chase [États-Unis] ; M. Maral Mouradian [États-Unis]Opioid peptides in Parkinson's disease: effects of dopamine repletion
000D33 (1991) Elliott J. Mufson [États-Unis] ; Lesa N. Presley [États-Unis] ; Jeffrey H. Kordower [États-Unis]Nerve growth factor receptor immunoreactivity within the nucleus basalis (Ch4) in Parkinson's disease: reduced cell numbers and co-localization with cholinergic neurons
000D40 (1991) Naji J. Riachi [États-Unis] ; Ramin A. Behmand [États-Unis] ; Sami I. Harik [États-Unis]Correlation of MPTP neurotoxicity in vivo with oxidation of MPTP by the brain and blood-brain barrier in vitro in five rat strains
000D55 (1990) R. Raisman-Vozari ; J.-A. Girault [États-Unis] ; S. Moussaoui ; C. Feuerstein ; P. Jenner ; C. D. Marsden ; Yves Agid [France]Lack of change in striatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in man
000D60 (1990) J. S. Schneider [États-Unis] ; C. J. Kovelowski Ii [États-Unis]Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys
000D72 (1989) Ross A. Clevens [États-Unis] ; M. Flint Beal [États-Unis]Substance P-like immunoreactivity in brains with pathological features of Parkinson's and Alzheimer's diseases

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/USA/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/USA/Analysis/ISSN.i -k "0006-8993" 
HfdIndexSelect -h $EXPLOR_AREA/Data/USA/Analysis/ISSN.i  \
                -Sk "0006-8993" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/USA/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    USA
   |étape=   Analysis
   |type=    indexItem
   |index=    ISSN.i
   |clé=    0006-8993
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024